Korean Ingredient PDRN Moves From Clinics Into Skincare Aisles

Dermatology clinics in Seoul, South Korea, have used polydeoxyribonucleotide, known as PDRN, in wound-healing treatments for years, and the ingredient is now turning up in serums, ampoules, and injectable treatments marketed well beyond South Korea, according to a report from MiNDFOOD. The report describes the ingredient as part of a wider wave of Korean beauty, or K-beauty, products reaching shelves in the United States, the United Kingdom, and other markets.

What Is PDRN Made From?

PDRN is built from fragments of DNA, most commonly sourced from salmon or trout, MiNDFOOD's report notes. The compound was originally developed for clinical use in South Korea to support tissue repair, which is why it carries a different reputation from plant-derived or synthetic actives more familiar to Western shoppers. Formulators describe the ingredient as working by signaling skin cells toward repair, a property tied to its original medical application rather than to cosmetic chemistry alone.

Why Is PDRN Spreading Beyond South Korea Now?

MiNDFOOD's report frames PDRN as a K-beauty ingredient that has moved quickly from specialist use into mainstream product marketing this year, riding the broader international popularity of Korean skincare routines. The report does not attribute the shift to a single brand or regulatory change, but it places PDRN alongside other ingredients that gained global attention after first circulating in South Korean clinics and online beauty communities.

How Is PDRN Applied — Serums or Injections?

According to the report, PDRN reaches consumers in two distinct forms. The first is topical: serums, ampoules, and sheet masks sold directly to shoppers for home use. The second is clinical: injectable formulations, sometimes described as "skin boosters," administered by practitioners in treatment settings rather than purchased over the counter. That split matters for anyone comparing products, since a topical serum and an in-clinic injection are regulated differently, formulated at different concentrations, and carry different safety considerations.

PDRN At a Glance

• Source material: DNA fragments derived from salmon or trout, per MiNDFOOD's reporting.
• Delivery formats cited in the report: topical serums and ampoules for home use, and injectable treatments administered in clinics.

How Does PDRN Compare With Retinol and Other Actives?

Retinol remains the reference point for most shoppers evaluating a new active ingredient, and the comparison is useful here. As Rey's Refined Radiance has explained, retinol and its relative retinal work primarily by accelerating cell turnover, which is why they are associated with fine lines and texture. PDRN is marketed around a different function: supporting the skin's repair processes rather than speeding up cell cycling. The two ingredients are not positioned as substitutes for one another in product marketing, and MiNDFOOD's report does not claim PDRN replaces retinol-based routines; it describes PDRN as an addition circulating alongside established actives rather than a replacement for them.

What Should Shoppers Check Before Buying PDRN Products?

Because PDRN appears in both over-the-counter cosmetics and in-clinic injectable treatments, the practical advice differs by format. A topical serum or ampoule falls under standard cosmetic-product expectations: patch testing before full use and checking ingredient concentration where it is listed on packaging. An injectable "skin booster" is a different category entirely, administered by a practitioner rather than self-applied, and carries the oversight that comes with any in-clinic procedure. General guidance for adopting a new active ingredient, including introducing it gradually alongside an existing routine, is covered in Rey's Refined Radiance's science-backed skincare tips. MiNDFOOD's report does not list specific brands or pricing for PDRN products, and this account does not supply figures the source material did not provide.

What is established, according to the report, is the trajectory: an ingredient with roots in South Korean wound-care medicine is now part of the vocabulary shoppers encounter when browsing K-beauty shelves abroad, sitting alongside more familiar actives rather than displacing them.

Does PDRN Have Clinical Backing Beyond Marketing Claims?

MiNDFOOD's report grounds PDRN's appeal in its medical origin rather than in cosmetic-industry testimonials, noting that the compound's use in tissue repair predates its adoption by skincare brands. That history distinguishes it from ingredients that debut directly in cosmetic marketing with no prior clinical application. The report does not cite peer-reviewed studies on cosmetic-grade topical PDRN specifically, and this account does not supply research findings the source material did not include. Shoppers weighing the ingredient against established actives are left, per the report, with a provenance argument — clinical wound care in South Korea — rather than published cosmetic-trial data.